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We presented a rare extratesticular neoplasm, papillary adenocarcinoma of rete testis, which manifested variable symptoms and
mimicked most frequently seen benign extratesticular lesions. Due to its rarity, the treatment is therefore uncertain. Our patient’s
clinical manifestations mimicked an inﬂammatory lump and underwent radical orchiectomy after pathological report had been
conﬁrmed. Unlike other reports, our patient survives and has a good outcome. No deﬁnite predictor and tumor marker can be
used to deﬁne the prognosis. Early diagnosis and surgical treatment may have a good outcome.
1.Introduction
Papillary adenocarcinoma of rete testis is an extremely rare
extratesticular neoplasm with only a few sporadic reports in
the literature [1]. The clinical manifestations of this tumor
may be variables and similar to most frequently seen benign
extratesticular lesions that make the diagnosis may be
delayed [2]. Due to its rarity, the treatment is therefore
uncertain. We reported a young patient with papillary ad-
enocarcinoma of rete testis whose clinical manifestations
mimicked an inﬂammatory lump. We also reviewed the lit-
eratures and reported its outcome.
2.CaseReport
A 30-year-old male patient came to outpatient department
presented with a swelling and tender left scrotal lump for
2 weeks. There were associated symptoms of dysuria and
frequency in urination within these days. He did not have
fever nor body weight loss. Physical examination revealed a
hard nodule at the head of left epididymis with severe ten-
derness. Ultrasonography of the scrotum revealed a 1.6cm
hyperechoiclesionoverleftepididymis(Figure 1).Theinitial
diagnosis was left epididymitis with an extratesticular lesion.
He underwent a partial epididymectomy with removal of
the extratesticular lesion in a transverse left scrotal incision
under spinal anesthesia after failed medical treatment for 1
week with vibramycin and acetaminophen. During opera-
tion,thishardmasswasmeasuredabout8mmlocatedonthe
headofepididymiswithanotherpapillarysolidnoduleabout
7mm protruded just between the left epididymis and testis.
There was a swollen left epididymis found during operation.
Microscopically, there were hyperchromatic cuboid and
columnar cells with papillary protrusions which fulﬁll the
c enterhilusoftestis(Figur es2and3).Thereweresomecalci-
ﬁcationsembedded.Thepartofepididymisappearednormal
with few microinﬁltrations to the head of epididymis. The
mass was identiﬁed to be papillary adenocarcinoma of rete
testis according to the Nochomovitz and Orenstein’s clas-
siﬁcations [3]. Serum α-fetoprotein (AFP) and β-human
chorionic gonadotropin (βHCG) were within normal lim-
its one week after partial epididymectomy. Computerized
tomography (CT) of the abdomen revealed no visible lymph
node in the retroperitoneal space or pelvic cavity. He further
underwent a left inguinal radical orchiectomy 1 month after
the ﬁrst operation. The ﬁnal pathological report revealed2 Case Reports in Urology
D 18.1 MM
Figure 1: Scrotal ultrasound showing a focal cystic paratesticular
mass with compressed testicular parenchyma (arrowhead).
(a)
(b)
Figure 2: Histological H&E stain of (a) normal microscopic
pictures of rete testis, and (b) hyperchromatic cells (100x).
no residual tumor in testis, epididymis, or the stump of
the dissected spermatic cord. There was no further adjuvant
treatment such as radiotherapy or chemotherapy. He had
been followed by serum AFP, βHCG, and abdominal CT
annually without evidence of tumor recurrence for at least
48 months.
(a)
(b)
Figure 3: Histological H&E stain of papillary protrusion of the
malignant cells ﬁlled in the lumen of rete testis. (a) (100x); (b)
(400x).
3. Discussions
To our best knowledge, papillary adenocarcinoma is a rarely
extratesticular malignancy with only about 60 cases reported
in the literatures [1, 4]. It tends to be found in the aged
patients with the peak incidence of 70 years (ranged from
17 to 91 years) [1, 4, 5]; only 6 patients were younger than
30 years old [4, 5] .T h em o s tr e p o r t e dc a s e sw e r ew h i t ea n d
occasionally seen in Africans and oriental persons.
The exact etiology of this tumor remains unknown.
The most common symptoms of papillary adenocarcinoma
included scrotal mass, indurations, pain, and swelling, which
mimicked an inﬂammation. The misleading symptoms may
delay the diagnosis and adequate treatment. It is diﬃcult
to make diﬀerential diagnosis with other extratesticular
lesions because adenocarcinoma of rete testis may present
with epididymitis, cryptorchidism, hydrocele, or inguinal
hernia [6–10]. There is no speciﬁc or sensitive marker
including APF and βHCG to detect the tumor earlier. The
diagnosis of adenocarcinoma of rete testis was often made
by the pathologist after surgery. There are 5 criteria for the
diagnosis of a primary tumor of the rete testis proposed by
Nochomovitz and Orenstein: (1) absence of histologically
similar extrascrotal tumor, (2) tumor centered on testicular
hilus, (3) morphology incompatible with any other type
of testicular or paratesticular tumor, (4) demonstrationCase Reports in Urology 3
of a transition between the unaﬀe c t e dr e t et e s t i sa n dt h e
tumor, and (5) a predominantly solid appearance [3]. Our
pathological pictures fulﬁll these criteria.
The prognosis of papillary adenocarcinoma seemed poor
in the earlier reports. Cancer cells may invade locally,
metastasize via lymphatics to the para-aortic and iliac lymph
nodes, or hematogenously spread to the sites of lung and
bone [1]. The involvement of pelvic lymph node had been
reported [3]. The treatment of choice is surgery which
includes radical orchiectomy and retroperitoneal lymph
node dissection (RPLND). Chemotherapy and radiotherapy
only have a limited beneﬁt to patients’ survival time [3].
These were 40∼50% patients died within the ﬁrst year after
diagnosis [3, 5, 7]. Three- and ﬁve-year disease-free survival
was49%and13%,respectively[7].Only37%ofthereported
patients had an average 8-month tumor-free survival after
diagnosis [3]. Unlike other malignancies, the stage cannot
aﬀect the prognosis or the choice of further treatment. Ac-
cordingtothestudyofSanchez-Chapadoetal.,thesizeofthe
tumor was the only independent predictor for the survival
time [7]. Therefore, prognosis seems not aﬀected by the
methods of treatment.
Usually, the patient was a sexualactive young man with
symptoms of inﬂamed left scrotum and lower urinary tract
symptoms which were considered as a common epididymitis
and urinary tract infection. The scrotal tumor was relatively
s m a l la n dw a sd i ﬃcult to be diﬀerentiated with a swollen
epididymis. It was lucky to identify the tumor from ultra-
sonography in a small size and early stage. After radical
orchiectomy, the patient had at least 48-month tumor-free
period. Good prognosis was probably due to the fact that
our patient was young with a small and early-stage tumor.
Although Sanchez-Chapado et al. suggested the beneﬁt of
RPLND [7], we did not perform RPLND to this patient
because of a clear-cut end of the spermatic cord and his
sexual active age. Sympathetic nerve ﬁber has a risk to be
disrupted during this procedure. That may result in loss of
seminal emission and cause ejaculation problem. We sug-
gested close followup by serial examinations, and the result
was good till now.
In conclusion, papillary adenocarcinoma of rete testis is
a rare extratesticular malignancy which may have a diverse
prognosis in diﬀerent age. No deﬁnite predictor and tumor
marker can be used to deﬁne its prognosis and method of
treatment. A better prognosis may be reached if diagnosis
and surgical were conducted treatment earlier.
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